News in brief: Sanofi off-loads drugs for bid

Merrill Lynch and BNP Paribas advised Sanofi-Synthélabo, the French pharmaceutical group, on the sale of two of its anti-thrombotic drugs as part of its assault to win Aventis, its Franco-German rival. European and US competition authorities ruled that it had to dispose of the drugs if its hostile €55.6bn ($67bn) bid for Aventis succeeded. GlaxoSmithKline, the world's largest pharmaceutical group, bought the drugs for €453m without the help of external financial advisers.

UBS hires Rushton from DrKW

WSJ Logo
How Trump Got His ‘Big, Beautiful Bill’ Across the Finish LineExternal link

How Trump Got His ‘Big, Beautiful Bill’ Across the Finish Line